We are exploring a new targeted treatment for patients with metastatic neuroendocrine prostate cancer. This study aims to assess its safety and effectiveness compared to existing therapies.
Health conditions and diseases that the clinical trial is designed to study and treat.
Metastatic Neuroendocrine Prostate Cancer is a rare and aggressive form of prostate cancer that has spread beyond the prostate gland to other parts of the body, often leading to symptoms such as weight loss, fatigue, and changes in hormone levels.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
